(PI and Co-I represent principal investigator and co-investigator, respectively.)
On-going
Research Grants Council, General Research Fund. Bypassing the hurdles to effective intracellular delivery of nucleic acids via gold@polydopamine plasmonic nanoworms. PI, 2021–2024. Innovation and Technology Fund, Midstream Research Project. A nanotechnology platform for profiling diabetes-related miRNA for precision medicine, Co-A (33% of the research project), 6/2021–11/2023. Research Grant Council, General Research Fund. Systemic delivery of microRNA for reducing atherosclerosis via RNA-coated nanoparticles, PI, 2020-2023. Research Grant Council, General Research Fund. "Bio-nano" interactions between hydrocarbyl-terminated nanoparticles and the cell: Endocytosis, trafficking, and exocytosis, PI, 2018-2021.
Completed
National Natural Science Foundation of China (NSFC) / Research Grants Council (RGC) Joint Research Scheme. Development of efficient gene carriers based on self-assembled DNA nanostructures and understanding their interactions with the cell, Hong Kong PI, 2017-2020. Research Grant Council, General Research Fund. A novel polydopamine@poly(adenylic acid) nanoparticle for crossing the blood-brain barrier and selectively targeting neurons in vivo, PI, 2016-2019. Research Grant Council: Early Career Scheme Grant. Mechanistic investigations of the “bio-nano” interactions between anisotropic bionanomaterials and the living system, PI, 2014-2017.
The Chinese University of Hong Kong, Shun Hing Institute of Advanced Engineering. Mechanism for the transcytosis of targeted nanoparticles across the blood-brain barrier, PI, 2014-2016.
Croucher Foundation: Postdoctoral Research Fellowship. Metal-DNA nanoconjugates as contrast agents for dual tumor detection and treatment, PI, 2011-2013.